Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Solid Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02499224
What this trial is testing

Safety and Pharmacokinetics Study of YYB101 in Advanced Solid Tumors Patients Who Are Refractory to Standard Therapy

Who this might be right for
Solid Tumors
CellabMED 39
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Study completedNCT00083213
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00387608
What this trial is testing

ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 23
Early research (Phase 1)Looking for participantsNCT06302621
What this trial is testing

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Who this might be right for
Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+1 more
Massachusetts General Hospital 32
Testing effectiveness (Phase 2)UnknownNCT01919866
What this trial is testing

Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells

Who this might be right for
Acute LeukemiasAplastic AnemiaChildhood Solid Tumor
University Children's Hospital Tuebingen 120
Testing effectiveness (Phase 2)Ended earlyNCT01295697
What this trial is testing

Study of EZN-2208 Pediatric Patients With Solid Tumors

Who this might be right for
Solid Tumors
Enzon Pharmaceuticals, Inc. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439279
What this trial is testing

Testing Trametinib as a Potential Targeted Treatment in Cancers With BRAF Genetic Changes (MATCH-Subprotocol R)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Looking for participantsNCT06541262
What this trial is testing

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Who this might be right for
NeuroblastomaEwing SarcomaOsteosarcoma+2 more
Milton S. Hershey Medical Center 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439227
What this trial is testing

Testing AZD1775 as a Potential Targeted Treatment in Cancers With BRCA Genetic Changes (MATCH-Subprotocol Z1I)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 33
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Early research (Phase 1)Ended earlyNCT01081808
What this trial is testing

Laboratory-Treated Autologous Lymphocytes, Aldesleukin, and Sargramostim (GM-CSF) in Treating Advanced Solid Tumors

Who this might be right for
NeoplasmsTumorsSolid Tumors+1 more
Roger Williams Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT00284817
What this trial is testing

Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer

Who this might be right for
Cancer
MedImmune LLC 17
Testing effectiveness (Phase 2)Study completedNCT01349660
What this trial is testing

Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
SCRI Development Innovations, LLC 88
Early research (Phase 1)UnknownNCT02223923
What this trial is testing

Phase I Study to Assess Safety of AZD6738 Alone and in Combination With Radiotherapy in Patients With Solid Tumours

Who this might be right for
Solid Tumour Refractory to Conventional Treatment
Royal Marsden NHS Foundation Trust 87
Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Early research (Phase 1)Not Yet RecruitingNCT07748117
What this trial is testing

A Clinical Study of GO321 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor Malignancies
GeneSail Biotech (Shanghai) Co., Ltd. 21
Testing effectiveness (Phase 2)UnknownNCT05501340
What this trial is testing

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Who this might be right for
Malignant Ascites
Second Affiliated Hospital of Soochow University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05662397
What this trial is testing

HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Who this might be right for
Solid Tumor, AdultRelapsed CancerRefractory Cancer
HotSpot Therapeutics, Inc 77
Next Page